Enhanced apoptosis as a possible mechanism to self-limit SARS-CoV-2 replication in porcine primary respiratory epithelial cells in contrast to human cells

被引:12
|
作者
Nelli, Rahul K. [1 ]
Phadke, Kruttika-S [2 ]
Castillo, Gino [1 ]
Yen, Lu [1 ]
Saunders, Amy [1 ,3 ]
Rauh, Rolf [3 ]
Nelson, William [3 ]
Bellaire, Bryan H. [2 ]
Gimenez-Lirola, Luis G. [1 ]
机构
[1] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Coll Vet Med, Ames, IA 50010 USA
[2] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Coll Vet Med, Ames, IA 50010 USA
[3] Tetracore Inc, Rockville, MD 20850 USA
关键词
CORONAVIRUS; INFECTION; SUSCEPTIBILITY; CHICKENS; PIGS;
D O I
10.1038/s41420-021-00781-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ability of SARS-CoV to infect different species, including humans, dogs, cats, minks, ferrets, hamsters, tigers, and deer, pose a continuous threat to human and animal health. Pigs, though closely related to humans, seem to be less susceptible to SARS-CoV-2. Former in vivo studies failed to demonstrate clinical signs and transmission between pigs, while later attempts using a higher infectious dose reported viral shedding and seroconversion. This study investigated species-specific cell susceptibility, virus dose-dependent infectivity, and infection kinetics, using primary human (HRECs) and porcine (PRECs) respiratory epithelial cells. Despite higher ACE2 expression in HRECs compared to PRECs, SARS-CoV-2 infected, and replicated in both PRECs and HRECs in a dose-dependent manner. Cytopathic effect was particularly more evident in PRECs than HRECs, showing the hallmark morphological signs of apoptosis. Further analysis confirmed an early and enhanced apoptotic mechanism driven through caspase 3/7 activation, limiting SARS-CoV-2 propagation in PRECs compared to HRECs. Our findings shed light on a possible mechanism of resistance of pigs to SARS-CoV-2 infection, and it may hold therapeutic value for the treatment of COVID-19.
引用
收藏
页数:10
相关论文
共 38 条
  • [1] Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
    Varghese, Finny S.
    van Woudenbergh, Esther
    Overheul, Gijs J.
    Eleveld, Marc J.
    Kurver, Lisa
    van Heerbeek, Niels
    van Laarhoven, Arjan
    Miesen, Pascal
    den Hartog, Gerco
    de Jonge, Marien, I
    van Rij, Ronald P.
    VIRUSES-BASEL, 2021, 13 (02):
  • [2] Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells
    Kumar, Nilima Dinesh
    ter Ellen, Bram M.
    Bouma, Ellen M.
    Troost, Berit
    van de Pol, Denise P., I
    van der Ende-Metselaar, Heidi H.
    van Gosliga, Djoke
    Apperloo, Leonie
    Carpaij, Orestes A.
    van den Berge, Maarten
    Nawijn, Martijn C.
    Stienstra, Ymkje
    Rodenhuis-Zybert, Izabela A.
    Smit, Jolanda M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (01)
  • [3] Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells
    de Souza, Gabriel Augusto Pires
    Le Bideau, Marion
    Boschi, Celine
    Ferreira, Lorene
    Wurtz, Nathalie
    Devaux, Christian
    Colson, Philippe
    La Scola, Bernard
    VIRUSES-BASEL, 2022, 14 (01):
  • [4] Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells
    Islam, Md Aminul
    Albarracin, Leonardo
    Melnikov, Vyacheslav
    Andrade, Bruno G. N.
    Cuadrat, Rafael R. C.
    Kitazawa, Haruki
    Villena, Julio
    PATHOGENS, 2021, 10 (06):
  • [5] Effective SARS-CoV-2 replication of monolayers of intestinal epithelial cells differentiated from human induced pluripotent stem cells
    Minami, Shohei
    Matsumoto, Naomi
    Omori, Hiroko
    Nakamura, Yutaka
    Tamiya, Shigeyuki
    Nouda, Ryotaro
    Nurdin, Jeffery A.
    Yamasaki, Moeko
    Kotaki, Tomohiro
    Kanai, Yuta
    Okamoto, Toru
    Tachibana, Taro
    Ushijima, Hiroshi
    Kobayashi, Takeshi
    Sato, Shintaro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Immunobiotic Lactobacilli Improve Resistance of Respiratory Epithelial Cells to SARS-CoV-2 Infection
    Islam, Md. Aminul
    Albarracin, Leonardo
    Tomokiyo, Mikado
    Valdez, Juan Carlos
    Sacur, Jacinto
    Vizoso-Pinto, Maria Guadalupe
    Andrade, Bruno G. N.
    Cuadrat, Rafael R. C.
    Kitazawa, Haruki
    Villena, Julio
    PATHOGENS, 2021, 10 (09):
  • [7] Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2
    Jang, Yunyueng
    Seo, Sang Heui
    ARCHIVES OF VIROLOGY, 2020, 165 (10) : 2205 - 2211
  • [8] Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals
    Subramaniyan, Bharathiraja
    Larabee, Jason L.
    Bodas, Manish
    Moore, Andrew R.
    Burgett, Anthony W. G.
    Myers, Dean A.
    Georgescu, Constantin
    Wren, Jonathan D.
    Papin, James F.
    Walters, Matthew S.
    VIRUSES-BASEL, 2021, 13 (08):
  • [9] Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line
    Liao, Yun
    Li, Xueqi
    Mou, Tangwei
    Zhou, Xiaofang
    Li, Dandan
    Wang, Lichun
    Zhang, Ying
    Dong, Xingqi
    Zheng, Huiwen
    Guo, Lei
    Liang, Yan
    Jiang, Guorun
    Fan, Shengtao
    Xu, Xingli
    Xie, Zhongping
    Chen, Hongbo
    Liu, Longding
    Li, Qihan
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2830 - 2838
  • [10] Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
    Ramirez, Santseharay
    Fernandez-Antunez, Carlota
    Galli, Andrea
    Underwood, Alexander
    Pham, Long, V
    Ryberg, Line A.
    Feng, Shan
    Pedersen, Martin S.
    Mikkelsen, Lotte S.
    Belouzard, Sandrine
    Dubuisson, Jean
    Solund, Christina
    Weis, Nina
    Gottwein, Judith M.
    Fahnoe, Ulrik
    Bukh, Jens
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (07)